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Abstract  
 
Objective 
To investigate if people with subjective memory complaints (SMC) but no objective deficits are at increased risk 
of developing mild cognitive impairment (MCI) and dementia.   
Methods 
Major electronic databases were searched till 03/2014 and a meta-analysis was conducted using inception 
cohort studies.   
Results  
Across 28 studies there were 29,723 unique individuals (14,714 with SMC and 15,009 without SMC) (mean 71.6 
years) followed on average for 4.8 years through to dementia.  The annual conversion rate (ACR) of SMC to 
dementia was 2.33% (95% CI = 1.93% - 2.78%) a relative risk (RR) of 2.07 (95% CI = 1.76 to 2.44) compared to 
those without SMC (n=15,009). From 11 studies the ACR of developing MCI was 6.67% (95% CI = 4.70 - 8.95%). 
In long-term studies over 5 years, 14.5% (9.67 -19.1%) of people with SMC developed dementia and 26.6% 
(95% CI =15.3-39.7) went on to develop MCI.  The ACR from SMC to dementia and MCI were comparable in 
community and non-community settings.   
Conclusion 
Older people with SMC but no objective complaints are twice as likely to develop dementia as individuals 
without SMC.  Approximately 2.3% and 6.6% of older people with SMC will progress to dementia and MCI per 
year.   
 
Summations 
  
• Among people with SMC but without objective complaints, the annual conversion rate (ACR) to MCI is 
6.6%, whilst it is 2.3% to dementia, compared to 1% in those without SMC 
 
• Over about 5 years, 24.4% of those with SMC will develop MCI, whilst 10.9% will convert to dementia, 
compared to 4.6% in those without SMC. 
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• Overall, the risk of developing dementia is double in those with SMC compared to those without SMC. 
 
• Considerations 
 
• It was not possible to stratify the results according to type of dementia or the diagnosis method. 
• A wide range of definitions were used to capture SMC and it was not possible to conduct subgroup  
analysis to determine if this influenced the results.   
• Most of the analysis had high heterogeneity and there was evidence of publication bias in some of the 
analyses.   
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Introduction 
Subjective memory complaints (SMC) are everyday memory and related cognitive concerns expressed by 
people who may or may not have deficits on objective testing. Although a definition of SMC has not been 
operationalized1 numerous self-report measures have been developed.2 In one large community survey about 
half of individuals reported minor memory problems.3 In a UK survey, 31.7% reported forgetfulness in the last 
month, while 6.4% had forgotten something important in the last week.4  A meta-analysis found that SMC were 
present in about 17% elderly people with no objective deficits.5 The presence of SMC is associated with distress, 
reduced mental health, wellbeing and quality of life 6 and difficulties undertaking activities of daily living.7  SMC 
also appears to be a risk factor for nursing home placement8, future mortality9 and is associated with increased 
healthcare costs.10  However, perceived memory complaints may not always be a sinister finding since only a 
small proportion of memory complaints are severe enough to interfere with daily life and many with SMC do 
not deteriorate more rapidly than usual.11 12 13  In addition, psychological factors such as depression influence 
expression of memory complaints14 and some authors have suggested there is a distinct subgroup that has 
non-organic causes.15 Indeed, considerable debate surrounds the relationship between subjective and 
objective memory complaints. SMC might not only to inform the current wellbeing of an individual, but also 
potentially predict future cognitive trajectory.16 To date, some groups have found low correlation with 
objective tests whilst others have found a significant relationship. 17 18 19 20 21 22 23 24 25 26 To some extent this 
could be due to methodological issues for example with cross-sectional designs. There is also an issue of lack of 
power as several small studies have yielded ambiguous results.27 28  It is therefore still unclear whether SMC 
complaints are a risk factor for future cognitive decline, where baseline objective cognition is normal. In order 
to clarify this, a meta-analysis of prospective longitudinal studies is required that considers the influence of 
baseline objective cognitive testing, follow-up duration and recruitment setting (community v specialist 
settings e.g. memory clinics). 
 
Aims 
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The primary aim of this study was to investigate the annual conversion rate (ACR) of people with SMC to a) MCI 
and b) dementia in prospective longitudinal studies.  The secondary aim was to establish the cumulative 
proportion of those with SMC who progressed to a) MCI and b) dementia over the course of follow up.  In 
addition, we sought to investigate if the conversion rates differed according to baseline objective cognitive 
testing, follow-up duration and recruitment setting.  Finally, we calculated relative risks (RR) comparing the 
progression to dementia in people with and without SMC at baseline (where both subgroups were recruited 
from the same centre). 
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Methods 
This systematic review is conducted in accordance with the MOOSE guidelines 29 following a predetermined 
protocol. 
Inclusion and Exclusion  
Studies were eligible that 1) included people with reported SMC at baseline, with or without a control group 
that did not have SMC. 2) Were prospective longitudinal studies with a follow up of at least 6 months 3)  
Measured objective cognitive performance including criteria for either MCI and/ or dementia (of any type) as 
an end point of the study using recognized diagnostic criteria (ICD10, or DSM IV).  If we identified studies that 
appeared eligible but did not report the variables of interest, the protocol stipulated that we contacted the 
corresponding authors in order to ascertain these.  We did not place any language restriction upon the 
eligibility of the searches.  If we encountered multiple studies from the same data set we included the largest 
study and/ or the study with the longest follow up period.  Studies were excluded that included participants at 
baseline that all had objective cognitive impairment.  We excluded studies that did not report the proportion of 
subjects with cognitive decline (for example those that reported means alone).  
 
Information sources and searches 
Three independent authors (AJM, HB, BS) searched Medline, Pubmed, PsycINFO and Embase from inception till 
March 2014.  This was supplemented by searches of Science Direct, Ingenta Select, Ovid Full text, Web of 
Knowledge and Wiley/Blackwell Interscience.  The key words used were (subjective or personal or complaints 
or concerns) and (memory or cogniti*) and (Alzheimer* or dementia or MCI or mild cognitive impairment).  In 
addition, the reference lists of all included articles were included and several leading experts in the field were 
contacted to ensure completeness of the data acquisition process.   
 
Data extraction 
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Three authors (HB, BS, AJM) independently extracted data from all eligible studies using a predetermined form 
(Available upon request from the corresponding author).  If any discrepancies were identified these resolved 
through discussion and with reference to the original manuscript and if necessary contact with the 
corresponding authors of the original articles.  The data collected from each manuscript included details of the 
study (including year, setting, time of follow up) and participant demographics (number at baseline, mean 
age, % female), details of how SMC was measured/ defined, the method of cognitive assessment and diagnosis 
of MCI and dementia (including type).  In addition, we extracted data on the number of people that progressed 
to MCI and dementia in each cohort and also those who were lost in follow up.   
 
Meta-Analysis 
We used the method previously described in a similar study from our group.30 Our main analysis was the 
pooled annual conversion rate (ACR) which is calculated by dividing the number of cases who progresses by the 
person years of observation in each type of study. Each studies ACR was pooled in a meta-analysis which 
weighted for both study size and follow-up (person years). This statistic tells the reader/clinician: how many 
similar patients would typically progress each year. A secondary analysis was the cumulative progression which 
uncorrected for years of observation. This statistic tells the reader/clinician: how many similar patients would 
typically progress over time. We calculated rates of progression as a proportion of those recruited at baseline 
(inception cohort method) rather than those that survived to follow-up, since this most closely resembles 
clinical practice when attempting to give estimates of prognosis. In addition very few studies provided 
information on drop-outs. We also calculated person years of observation in each type of study. Weighted 
proportion meta-analysis was used to adjust for study size using the DerSimonian-Laird model and to account 
for the anticipated heterogeneity.31   
 
In order to establish if people with SMC at baseline were more likely than those without SMC to develop 
dementia we calculated the relative risks (RR).  We stratified the results and conducted subgroup analysis to 
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see if the results differed when we only included studies without abnormal cognitive function at baseline, 
those with long (4> years) and in those in community or specialist settings.  The I2 statistic was calculated for 
each analysis to determine heterogeneity.32 In order assess the risk of bias we undertook a visual inspection of 
funnel plots and calculated the Harbord bias test.33.  
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Results 
Study selection, Study and participant characteristics 
From a total of 111 valid hits, we considered the full texts of 79 articles.  At the full text review stage 47 articles 
were excluded with reasons and 32 articles were included in the systematic review.  The full search strategy 
including the reasons for exclusion at the full text review is represented in figure 1.  Of 32 studies, 28 
considered progression of SMC to dementia. .34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59  60 61  
11 considered progression of SMC to MCI. 43  46 51  52 53 55 60 62 63 64  65  
Insert figure 1 about here 
Across the 32 studies a sample of 29,723 unique individuals were represented including 14,714 individuals with 
SMC and 15,009 without SMC at baseline. The mean age of participants was 71.6 years and the percentage of 
females was 46.8%. Looking at studies of conversion to dementia, the majority of studies (21/28) recruited 
patients from the community or primary care (with community follow-up) but 7 were conducted in specialist 
settings (largely memory clinics).  The method for diagnosing dementia and (21/28) used standard diagnostic 
criteria (DSM IV/ ICD 10). Non-standard criteria were used by 7 studies.34 36 43 45 47 49 53 Where MCI was studied, 
all used Peterson criteria.66 Objective cognitive performance was clearly documented at baseline in all but 4 
studies. The most commonly used objective measurement of cognition was MMSE and the average score was 
28.2.  Fourteen of the included studies contained a group at baseline with and without SMC.  The average 
duration for the follow up was 4.8 years for those progressing to dementia and 4.1 years for those potentially 
progressing to MCI.  Further details of the included studies are presented in table 1.   
Insert table 1 about here 
Meta-analysis of the progression from SMC to mild cognitive impairment  
1. Annual Conversion Rate 
Data from 11 studies 43 46 51 52 53 55 60 62 63 64 were pooled and confirmed that the ACR of people with SMC 
developing MCI was 6.67% (95% CI = 4.70% to 8.95) (figure 2).  This represented 14,287 person years of 
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observation. There was no publication bias (Harbord: bias = 3.24, P = 0.229) but there was high heterogeneity 
(I² = 94.1%, 95% CI = 91.9% to 95.5%).  
Insert figure 2about here 
2. Cumulative Conversion Proportion from SMC to MCI 
Over a mean follow-up period of 4.1 years, data from 11 studies established that 24.47% (95% CI = 17.0 to 
32.%7) of those with SMC went on to develop MCI. 43 46 51 52 53 55 60 62 63 64 There was high heterogeneity (I² = 
94.5%; 95% CI = 92.5% to 95.8%) but there was not any evidence of publication bias (Harbord bias = 2.994, P = 
0.17). 
 
Subgroup analysis of progression of SMC to MCI 
Over a mean of 5.3 years follow up, the pooled proportion of people with SMC that converted to MCI in the 
community studies was 34.2% (95% CI = 20.86 to 49.0; I² = 97.6%, Harbord bias=10.1 P = 0.01).  The pooled 
cumulative proportion of people with SMC converting to MCI over a mean of 3.3 years in specialist non-
community settings was 16.48% (95% CI = 10.53 to 23.44; I² = 66.7%, Harbord: bias = -0.76  P = 0.76).  Next we 
calculated the ACR from SMC to MCI according to setting and this was 7.7% (95% CI 4.8% to 11.2%) in 
community settings and 5.6% (2.8 = 9.5%) for specialist non community settings.  It was possible to pool the 
data from 7 studies that excluded participants with no clear cognitive test score at baseline and this established 
that 21.80% (95% CI = 14.76 to 29.79; I² = 93%, Harbord: bias = 2.118, P = 0.33) went on to develop MCI.  
Finally, we pooled the data from 5 long term studies that followed participants over 4 years (with a mean of 
5.96 years) and this established that the proportion of those with SMC that developed MCI was 26.7% (95% CI 
= 15.39 to 39.74; I² = 93.4, Harbord: bias = 0.56 P = 0.91). 46 53  55 60 64 
 
Meta-analysis of the progression from individuals without SMC to dementia (healthy controls) 
1. Annual Conversion Rate 
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From 14 studies involving healthy older adult controls without SMC and without objective cognitive complaints 
the pooled ACR was 1.00% (95% CI = 0.71% to 1.34%).  There was high heterogeneity (I² = 93.1%, 95% CI = 
90.5% to 94.6%) and no indication of publication bias (Harbord bias = 0.558, P = 0.741).    
2. Cumulative Conversion Proportion  
Across 14 studies involving 14,949 healthy older controls without SMC and without objective complaints that 
were conducted over four years established that 4.6% (95% CI = 2.8% to 6.9%) of participants developed 
dementia.  The data was heterogeneous (I² = 96.3% (95% CI = 95.3% to 96.9%) but there was no evidence of 
publication bias (Harbord bias= -2.3, P = 0.39).   
Meta-analysis of the progression from SMC to dementia 
1. Annual Conversion Rate 
28 studies examined progression of SMC to dementia representing 86,200 person years of observation.34-61 The 
ACR of people with SMC developing dementia was 2.33% (95% CI = 1.93% to 2.78%) (figure 3). There was high 
heterogeneity (I² = 89.2%; 95% CI = 86% to 91.4%) and some evidence of publication bias (Harbord: bias = 2.55 
P = 0.01) but the funnel plot was symmetrical (figure 2b).   
Insert figure 3 about here 
2. Cumulative Conversion Proportion from SMC to dementia 
From 28 studies34-61 10.99% (95% CI = 8.20 to 14.12) of those with SMC developed dementia over the course of 
the follow up period of 4.8 years. 34-61   There was high heterogeneity (I² = 95.4%, 95% CI = 94.6% to 96.1%) but 
the funnel plot was symmetrical and the Harbord bias test did not indicate any evidence of publication bias (-
0.7154, P = 0.64).   
Subgroup analysis of progression of SMC to dementia 
From 21 studies conducted in the community the cumulative conversion from SMC to dementia was 10.79% 
(95% CI 7.7 to 14.3, I² = 96.4%, Harbord: bias = -1.10 P = 0.6101) over a mean of 5.2 years.  The cumulative 
proportion of people with SMC that developed dementia in specialist settings was 11.7% (95% CI = 5.0 to 20.7, 
I² = 83.8%, Harbord: bias = -2.20 P = 0.5378) over a mean of 3.2 years. After correcting for follow-up duration, 
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the ACR for community studies was 2.2% (95% CI = 1.8% to 2.6%) and 3.2% (95% CI = 1.1% to 6.3% in specialist 
non-community studies it was).  Pooled data from 22 studies excluding participants with no clear cognitive test 
score at baseline established that 11.5% (95% CI = 8.18 to 15.36, I² = 95.4%, Harbord: bias = -1.189, P = 0.46) 
went on to develop dementia.  The pooled cumulative progression proportion of those with SMC to dementia 
among 14 long term studies that followed participants over 4 years or more (a mean of 6.8 years) was 14.05 
(95% CI = 9.67 to 19.08, I² = 95.6%, Harbord: bias = -1.1132 P = 0.59). 41  42 45  46 48  47  49  54  55  57 58 59 60 
 
Meta-analysis comparing the risk of developing dementia in people with and without SMC 
It was possible to compare the risk for developing dementia in people with and without SMC using data from 
14 studies, over a mean follow up of 4.94 years. The pooled RR was 2.07 (95% CI = 1.77 to 2.44) establishing 
that people with SMC (n=3,821) were twice more likely than those without SMC (n=15,009) to develop 
dementia (figure 4).  The data was not heterogeneous (I² = 17.5% (95% CI = 0% to 56.2%) and there was no 
evidence of publication bias (Harbord = 0.93, P = 0.08).   
Insert figure 4 here 
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Discussion 
 To our knowledge this is the first study to perform a quantitative data synthesis of studies reporting 
rates of progression of those with SMC to MCI and dementia.  When considering dementia, we included 28 
robust cohort studies and found that the overall ACR rate among 86,200 person years of observation was 
2.33% in those with SMC at baseline compared to 1% in those without SMC. This represents a twofold 
increased risk of developing dementia in those with vs without SMC (RR 2.07, 95% CI= 1.77 to 2.44, p<0.001). 
The overall proportion that converted to dementia from 28 studies was 10.99% over the follow up period of 
about 5 years although it was 14% in long term studies that followed participants over a mean of 6.8 years.  
When we conducted subgroup analyses comparing studies in community or specialist non-community settings 
(mainly memory clinics) we found cumulative conversion rates from SMC to dementia at 10.7% over 5.2 years 
and 11.7% over 3.2 years respectively.  Further to this, our results demonstrate that people with SMC are at 
increased risk of developing future MCI. The ACR for those with SMC to convert to MCI was 6.67% and the 
cumulative conversion proportion was 24.4%.  When we conducted subgroup analysis we found that the 
cumulative conversion from SMC to MCI was 34.2% over 5.3 years in community settings and  
16.5% over 3.3 years in specialist non community settings (mainly memory clinics).  The sub group analysis 
based on setting determined that the ACR from SMC to dementia and MCI were broadly similar in community 
and specialist non community settings.  Taken together, our results indicate that people with SMC are at 
increased risk of MCI and dementia.   
 
There has been considerable debate about the significance of SMC in anticipating future cognitive decline. 
Several groups have reported that SMC are more a reflection of health anxiety than genuine cognitive 
symptoms, particularly in mid-life.4 Against this, some studies have observed biological changes associated with 
SMC. Studies have shown that older people with SMC have increased rates of white matter lesions, temporal 
atrophy or hypometabolism and raised CSF biomarkers.67 68 69 70 71 72 73 74 Such biological changes may occur in 
the absence of objective decline suggesting SMC may be a possible early marker of future 
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deterioration.75 76 77 78 For example, several studies have found that SMC scores as well as a decrease of self-
confidence about memory abilities in elderly subjects (or a subgroup of elderly who are ApoE4 carriers) may be 
related to the neuropathological hallmark of AD measured with PiB-positron emission tomography.76 78 79  
These results may be supported by longitudinal biological studies showing SMC at baseline is linked with 
subsequent change in hippocampal volume.80 
 
Awareness of cognitive deficits has a u-shaped distribution being low with mild complaints, rising but then 
generally low with severe cognitive impairment.81 82 83 84 85 Insight is usually preserved in mild dementia and in 
mild cognitive impairment (MCI). 86  Our findings in relation to SMC should be considered in the context of 
previously reported research in relation to MCI. In the case of MCI, Mitchell and Feshki found an ACR of 6.7% 
(95% CI = 4.6–9.1%) and a RR of 13.8 (95% CI = 8.44–22.6) in relation to progression of MCI to dementia.30 Thus 
SMC are a much lower risk of progression than MCI (about 1/3 numerically) but still clearly important. SMC 
forms a core component of the criteria for MCI.87 88 It may be therefore than SMC contributes part of the 
significance of MCI but MCI and SMC are not synonymous prognostically.89 A key issue for MCI is that function 
must be unimpaired or minimally impaired in current guidelines.  However impaired function can co-occur with 
SMC even in the absence of objective impairment. Data from the Spanish Neurological Diseases in Central 
Spain study (NEDICES) cohort involving 1,073 participants found that of 730 with pure SMC, 18.1% had 
significantly impaired function and 9.5% had severely impaired function measured by the Pfeffer scale.90 It is 
likely that SMC and function are independent predictors of decline, but this requires further study. 
 
Our results suggest that SMC should not merely be considered as a benign age related phenomenon since our 
meta-analysis demonstrates that those with SMC are at significantly increased risk of future cognitive decline, 
particularly of MCI.  Yet there is considerable heterogeneity in samples with SMC. For example types of 
complaints may vary in mid-life vs late life.91 Community dwelling participants with no functional limitation but 
isolated SMC are likely to be quite different from memory clinic attendees with SMC.  We found that there 
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were comparable cumulative proportions with SMC that converted to dementia in community or specialist 
settings (10.7% and 11.7% respectively) although the mean follow up for community settings was two years 
less in on average (5.2 v 3.2 years) and is therefore of little surprise.  When we investigated the ACR from SMC 
to dementia this was comparable for community settings (2.2%) and non-community settings (3.2%). 
Although we found that 34.2% of people with SMC converted to MCI in community settings compared to 16.5% 
in specialist settings after correcting for follow-up the ACR the results were similar (7.7% and 5.6% respectively). 
The similarities in ACR according to setting are likely to be because the subgroup analysis were underpowered.   
Clinically the approach to the management of SMC may have to be revised in light of these findings. SMC may 
be amenable to treatment in the absence of objective decline92 and the next step is to study whether 
amelioration of SMC at early stage influences the rate of progression of cognitive decline.   
 
We wish to acknowledge the following limitations. We had limited access to younger samples. As a result the 
prognosis of SMC in mid-life is uncertain. We were unable to stratify outcomes by types of dementia.  This 
could be important as certain dementias may be more strongly liked with a long-prodromal period and high 
perceived subjective decline.  In addition, due to limitations in the data it was not possible to establish if the 
method of diagnosing dementia (e.g. DSM-IV or ICD 10) influenced our results.  Therefore, future research 
should investigate this.  Another important limitation is that as expected, the studies included in our review 
adopted a wide range of methods to capture SMC, which is difficult to overcome since there is currently no 
gold standard to define SMC. Heterogeneity and lack of reporting of exact methods in primary studies 
prevented us from conducting subgroup analysis to see if the method of defining SMC affects the conversion 
rates to MCI and dementia. This is therefore another recommended topic for future research. We had modest 
duration of follow-up with a maximum of 8 years. It is therefore unknown whether the rate of progression 
accelerates, stays stable or declines with time.  It is important to also note that almost all of the results within 
our review had substantial heterogeneity.  Finally in some cases there was evidence of publication bias.   
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Conclusion 
SMC may be a clinically meaningful indicator of future cognitive decline, with individuals experiencing SMC at 
increased risk of developing MCI and dementia. However the context and setting of the SMC report remains 
important.  
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Table 1 – details of included studies  
Study Number 
with SMC 
at 
baseline 
SMC 
participant 
characteris
tics 
Settings Method of assessing SMC Follow up 
time (yrs) 
Investigated 
MCI and/ or 
dementia 
Method of diagnosing 
dementia/ MCI 
Schofield 1997 23 
75.5 years, 
7.5% female community 
“Do you have problems with your 
memory?” 1 
Dementia  
AD(NINCDS)  
Wang 2004 87 
74.6 yrs, 
14.2% female community 5 specific questions 5.2 
Dementia 
DSMIV+AD(NINCDS) 
Glodzik-
Sobanska 2007 187 
67 yrs, 15.9% 
females volunteers GDS 2  8.8 
Dementia  
MMSE  
Geerlings 1999 250 
74.5 yrs, 
58.5% 
females community 
do you have complaints about your 
memory 3.2 
Dementia 
DSM IIIR or AGECAT + MMSE 
25v26 +DSMIV 
Diniz 2009 62 
70.6 yrs, 9.8% 
females,  memory clinic 
subjective cognitive complaint, 
preferably corroborated by an informant; 
in the course of diagnosis MCI 3.19 
Dementia  The diagnosis of MCI was 
made according to the 
following criteria: (1) 
subjective cognitive 
complaint, preferably 
corroborated by an 
informant; (2) objective 
cognitive impairment in the 
neuropsychological 
assessment; (3) preserved 
global intellectual function 
St John & 
Montgomery 
(2002) 293 75.3 yrs community 
"Please tell me if you had memory loss in 
the past year. You can just answer yes or 
no. 5 
Dementia 
DSM IIIR  
Kim et al (2006) 135 
71.3 yrs, 
53.9% 
females community 
series of questions from the Geriatric 
Mental State Schedule 2.4 
Dementia 
DSMIV by expert panel, 
MMSE 
van Oijen et al 
(2007) 
1309 
69.5 yrs, 60% 
females community 
Single Question : “Do you have memory 
complaints?” 9 
Dementia  CAMDEX (three 
step_MMSE+GMS+CAMDEX)
+DSMIIIR+AD(NINCDS) 
Tobiansky et al 
(1995) 84 
75.9 yrs, 66% 
females  community Short-CARE 2 
Dementia 
GMS-A, HAS, CAMCOG 
Mol et al (2006) 
94 
67.4 yrs, 46% 
females community 
‘Do you consider yourself to be 
forgetful?' 6 
Dementia  
MMSE < 24 
Nunes et al 
(2010) 15 
68.8 yrs, 
65.1% memory clinic 
SMC scale - 10 questions concerning 
difficulties in daily life memory tasks 3.5 
Dementia and 
MCI BLAD + DSMIVTR 
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females 
Waldroff (2012) 177 
74.8 yrs, 
61.4% 
females Community / GP 
Self administered question ‘How would 
you describe your memory?’ ‘less good’, 
‘poor’ or ‘miserable’=SMC, ‘excellent’ or 
‘good’=no SMC 4 
Dementia 
ICD 10 
Jessen et al 
(2014) 1061 
79.7 yrs, 
64.8% 
females GP 
Do you feel like your memory is 
becoming worse? Possible answers were 
no; yes, but this does not worry me; and 
yes, this worries me. 6 
Dementia  
DSM IV and ICD10 MMSE 
Chary et al 
(2013) 45 74.7 yrs Community 
4 questions used:  Coded as yes/ no 1. Do 
you frequently have forgetfulness in 
activities of daily living (ADLs; shopping 
list, in using household appliances, and 
so forth)? 
2. Do you frequently have difficulties in 
retaining or remembering new simple inf 10 
Dementia 
DSM III R dementia and 
NINCDS-ADRDA 
O'Brien 1992 68 
67.2 yrs, 70.3 
female memory clinic 
At follow-up, patients and spouses were 
questioned about any deterioration in 
memory, personality and social 
functioning since the initial assessment. 3.1 
Dementia  
ICD-10 
Gironell 2005 116 
68.8 yrs, 
56.9% female memory clinic unclear 2.3 
Dementia & 
MCI Unclear 
Prichep 2006 44 
72 yrs, 15.2% 
female community GDS2 7 
Dementia and 
MCI NINCDS-ADRDA 
Rountree 2007 17 
69 yrs, 16% 
females,  memory clinic Part of Petersen’s clinical criteria for MCI 4.8 
Dementia Wechsler Memory Scale-
Revised (WMS-R), Logical 
Memory II (LM II) 
impairment 
Visser 2009 60 
68.6 yrs, 
47.6% 
females memory clinic NR 2 
Dementia  
DSMIV + NINCDS-ADRDA 
Reisberg 1986 40 
70.6 yrs, 
53.8% 
females community GDS 3.6 
Dementia 
Unclear 
Jorm et al 
(1997) 
721 N/A community 
"Overall , do you feel you can remember 
things as well as you used to? That is is 
your memory the same as it was earlier 
in life?"  3.6 
Dementia  
MMSE, ICD-10, DSM-III-R 
Schmand et al 
(1996) 357 
58.3% 
females community 
10 questions on subjective memory 
complaints derived from CAMDEX 3 
dementia 
DSMIIIR + CAMCOG 
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Reisberg et al 
(2010) 166 
67.5 yrs, 63% 
females Community GDS 6.8 
Dementia and 
MCI 
MMSE, BCRS (Brief Cognitive 
Rating Scale) 
Jessen et al 
(2010)  
1388 
79.7 yrs, 
64.1% 
females Community 
Do you feel like your memory 's 
becoming worse? 3 
Dementia 
DSM-IC, ICD-10, MMSE 
Jessen et al 
(2011) 
1764 
80.1 yrs, 
65.5% 
females Community 
Do you feel like your memory 's 
becoming worse? 3.81 
Dementia 
DSM-IV, ICD-10, MMSE 
Peres et al 
(2011) 
2901 
74.8 yrs, 
58.8% 
females Community 
3 Questions: 1)forgetfulness in daily 
activities, 2) difficulties in retrieving and 
remembering new information, 3) 
difficulties in remembering or retrieving 
old memories. 15 
Dementia 
DSM-IIIR, MMSE 
Gallassi et al 
(2010) 92 63.26 yrs 
University Hospital 
of the Department 
of Neurological 
Sciences of Bologna unclear 4 
Dementia and 
MCI 
DSM-IV 
van Harten et al 
(2013) 128 
60, yrs, 48% 
females Outpatient clinic 
presented with cognitive complaints, but 
cognitive and laboratory investigations 
were normal and criteria for MCI, 
dementia, or any other neurologic or 
psychiatric disorders known to cause 
cognitive complaints were not met 4 
Dementia and 
MCI  
NINCDS-ADRDA 
Elfgren (2010) 
24 59.6 yrs, 
57.6% female Outpatient clinic Unclear 3 
MCI only 
DSM-IV, MMSE 
Johansson et al 
(1997) 
147 
86.85 yrs, 
64% females Census data 
4 questions: 
1) on the whole, do you think your 
memory is good or poor? 2) Do you think 
you have a problem with your memory 
that makes your life more difficult? 3) Do 
you think that your memory has gotten 
worse over the past 2 years? 4) On the 
whole, do you think that 2 
MCI only MMSE, DSM-III-R 
Luck et al 
(2010a) 
519 81.3 yrs, 
73.9% female Community 
Single item question: Do you have 
problems with your memory? 8 
MCI only  DSM-III-R, DSM-IV, ICD-10 
Luck et al 
(2010b) 
2331 80.1 yrs, 
65.5% female GP 
Single item question: Do you have 
problems with your memory? 3 
MCI only DSMIII, DSMIV, ICD-10 
Key: AD= Alzheimer’s disease, yrs = years, MCI= mild cognitive impairment, BCRS= brief cognitive rating scale, MMSE = mini mental state examination, 
NINCDS ADRDA=Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria, CAMCOG= 
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Cambridge Examination of Mental Disorders, CAMDEX= Cambridge Examination for Mental Disorders of the Elderly, GDS= global deterioration scale, 
AGECAT= Automated Geriatric Examination for Computer-Assisted Taxonomy, GMS= Geriatric Mental State, Short-CARE= Comprehensive Assessment and 
referral Evaluation,  
 
Figure2 random effects ACR of SMC to MCI among 11 studies  
 
 
 
ACR = 6.7% (95% CI = 4.7% to 8.9%) 
I2= 94.1%  
Proportion meta-analysis plot [random effects]
0.0 0.1 0.2 0.3
combined 0.067 (0.047, 0.089)
van Harten et al (2013) 0.021 (0.011, 0.038)
Elfgren (2010) 0.028 (0.003, 0.097)
Luck et al (2010) 0.033 (0.028, 0.039)
Nunes et al (2010) 0.038 (0.005, 0.131)
Gallassi et al (2010) 0.043 (0.025, 0.070)
Luck et al (2010) 0.050 (0.045, 0.055)
Reisberg et al (2010) 0.063 (0.049, 0.079)
Prichep 2006 0.065 (0.040, 0.099)
Visser 2009 0.100 (0.053, 0.168)
Gironell 2005 0.112 (0.077, 0.157)
Johansson et al (1997) 0.239 (0.193, 0.290)
proportion (95% confidence interval)
Figure 2 – Random effects ACR of SMC to dementia among 28 studies  
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Proportion meta-analysis plot [random effects]
0.00 0.05 0.10 0.15 0.20 0.25
combined 0.0233 (0.0193, 0.0278)
van Harten et al (2013) 0.0039 (0.0005, 0.0140)
Mol et al (2006) 0.0053 (0.0011, 0.0155)
Visser 2009 0.0083 (0.0002, 0.0456)
Jessen et al (2014) 0.0104 (0.0080, 0.0132)
Jorm et al (1997) 0.0108 (0.0072, 0.0156)
Reisberg 1986 0.0139 (0.0017, 0.0493)
Peres et al (2011) 0.0142 (0.0131, 0.0154)
van Oijen et al (2007) 0.0146 (0.0125, 0.0169)
Schmand et al (1996) 0.0149 (0.0086, 0.0241)
Diniz 2009 0.0152 (0.0031, 0.0437)
Reisberg et al (2010) 0.0168 (0.0102, 0.0262)
Geerlings 1999 0.0200 (0.0115, 0.0323)
Jessen et al (2010) 0.0207 (0.0166, 0.0254)
Jessen et al (2011) 0.0223 (0.0189, 0.0261)
Prichep 2006 0.0227 (0.0092, 0.0463)
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Gallassi et al (2010) 0.0272 (0.0131, 0.0494)
O'Brien 1992 0.0285 (0.0105, 0.0609)
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St John & Montgomery (2002) 0.0314 (0.0231, 0.0417)
Waldroff (2012) 0.0353 (0.0230, 0.0517)
Rountree 2007 0.0368 (0.0076, 0.1037)
Nunes et al (2010) 0.0381 (0.0046, 0.1309)
Tobiansky et al (1995) 0.0417 (0.0169, 0.0840)
Schofield 1997 0.0435 (0.0011, 0.2195)
Glodzik-Sobanska 2007 0.0468 (0.0371, 0.0581)
Kim et al (2006) 0.0586 (0.0357, 0.0901)
Gironell 2005 0.1274 (0.0899, 0.1735)
proportion (95% confidence interval)
Figure 2b Funnel plot 
 
 
 
Begg-Mazumdar: Kendall's tau = 0.190476, P = 0.1621 
Harbord: bias = 2.552389, P = 0.0123 
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Figure 4: Relative risk comparing development of dementia among those with and without SMC 
 
 
 
Pooled relative risk = 2.07 (95% CI = 1.76 to 2.44) 
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